Interim report
Page 1
August 4, 2026 Listing Department Code: 531 335 BSE LIMITED P. J. Towers, Dalal Street, Mumbai–400 001 Listing Department Code: ZYDUSWELL NATIONAL STOCK EXCHANGE OF INDIA LIMITED Exchange Plaza, C/1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai–400 051 Sub: Outcome of Board Meeting Ref.: Unaudited financial results for the quarter ended on June 30, 2026, pursuant to regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“the Listing Regulations”) Dear Sir / Madam, The Board of Directors at their meeting held today i.e. August 4, 2026, based on the recommendations of the Audit Committee, approved the unaudited financial results for the quarter ended on June 30, 2026. In this regard, please find enclosed the following: 1. the unaudited financial results (standalone and consolidated) for the quarter ended on June 30, 2026, reviewed by the Audit Committee and taken on record by the Board of Directors, today i.e. August 4, 2026 pursuant to regulation 33 of the Listing Regulations. 2. the Limited Review Reports of Mukesh M. Shah & Co., Chartered Accountants and the Statutory Auditors of the Company certifying the limited review of the unaudited financial results (standalone and consolidated) of the Company for the quarter ended on June 30, 2026 pursuant to regulation 33 of the Listing Regulations.
Page 2
The Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed until Thursday, August 6, 2026, and shall re-open for trading on and from Friday, August 7, 2026 for all the Directors and Designated Persons of the Company. The Board meeting commenced at 11:30 a.m. and concluded at 12:15 p.m. Please find the same in order. Thanking you, Yours faithfully, For, ZYDUS WELLNESS LIMITED NANDISH P. JOSHI COMPANY SECRETARY & COMPLIANCE OFFICER Encl.: As above
Page 3
MU KESH M. SHAH & co. CHARTERED ACCOUNTANTS INDEPENDENT AUDITOR'S REVIEW REPORT ON REVIEW OF INTERIM STANDALONE FINANCIAL RESULTS To, The Board of Directors, Zydus Wellness Limited 1. We have reviewed the accompanying statement of Standalone Unaudited Financial Results of Zydus Wellness Limited ['the Company'], for the quarter ended on June 30, 2026 ['the Statement'] attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended ("the Listing Regulations"). 2. This statement, which is the responsibility of the Company's Management and approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34, 'Interim Financial Reporting' ('Ind AS 34'), prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the statement based on our review. 3. We conducted our review in accordance with the Standard on Review Engagement (SRE) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Institute of Chartered Accountants of India (ICAI). A review of interim financial information consists of making inquiries, primarily of the Company's personnel responsible for financial and accounting matters and applying analytical and other review procedures . A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under Section 143(10) of the Companies Act, 2013 and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. Place: Ahmedabad Date: August 4, 2026 UDIN: .2Go3 o '~0OTPEY Y 2.4 t4- +91-79-2647 2000Icontact@mmsco.inIwww.mmsco.in For Mukesh M . Shah & Co Chartered Accountants Firm Regn. No. 106625W Mukesh M. Shah Partner Membership No. 030190 7 th Floor, Heritage Chambers, Behind Bikanerwala Sweets, Near Azad Society, Nehru Nagar, Ahmedabad-380015
Page 4
zyd~ Zydus Wellness Limited Registered office : Zydus Corporate Park, Scheme No. 63, Survey No. 536 Khoraj (Gandhinagar), Near Vaishnodevi Circle, wellness Sarl<hej-Gandhinagar Highway, Ahmedabad 382 481. ••~••I ~,f\ ........ , ,'to Tel. No. /+91-79) 4804 0000 Website: www.zvduswellness.com CIN: L15201Gl1994PLC023490 Statement of Standalone Unaudited Financial Results for the Quarter ended June 30, ·2026 , in Million Ouarter Ended Year Ended June March June March Sr. No. Part.iculars 30, 2026 31,2026 30, 2025 31, 2026 [Unaudited] [Unaudited] [Unaudited] [Audited] Refer Note 7 1 Income a Revenue from operations i Sales 1,353 1,114 1,303 5,284 ii Other operating income 177 212 106 537 Total Revenue from operations 1,530 1,326 1,409 5,821 b Other income 49 48 7 119 Total Income 1,579 1,374 1,416 5,940 2 Expenses a Cost of materials consumed 1,021 831 840 3,583 b Purchases of Stock-in-Trade 24 - C Changes in inventories of finished goocs, work-in-progress and stock-in-trade 3 20 (28) 59 d Employee benefits expense 153 143 174 568 e Finance costs 30 31 23 110 f Depreciation and amortisation expense 63 63 60 250 Q other expenses 211 171 269 825 h Net gain on foreign currency transacti_ons - (37) (1) (55) Total Expenses 1 505 1 222 1 337 5 340 3 Profit before exceptional items and tax [1 - 2] 74 152 79 600 4 Exceptional items rRefer Not~ 51 - - 112 5 Profit before tax (3-4 J 74 152 79 488 6 Tax expense a Current tax 2 1 8 40 b Deferred tax 17 18 25 72 Total tax expense 19 19 33 112 7 Net Profit [5-6] 55 133 46 376 8 Other Comprehensive InC"ome (OCI] a Items that will not be r~!assified to profit or loss Re-measurement loss on mst employment defined benefit plan - 1 (2) (4) Income tax effect on abo\'~ items - - 1 Total Other Comprehensive Income (n,:,t of tax] - 1 12) ·(3) 9 Total Comprehensive Income (7+8] 55 134 44 373 Paid-up equity share rapital rFace Value { 2/- each] 636 636 636 636 Reserve excluding Revaluation Reserve [I.e. other equity] 39,690 Earnings per share rnot. annualised for the quarter] rRefer Note 41 a Basic r~l 0.17 0.42 0.14 1.18 b Diluted m 0.17 0.42 0.14 1.18 Notes: I. The above financial results were re.viewed by the Audit Committee and then approved by the Board of Directors at their meeting held on August 4, 2026. 2. The above financial results have been prepared in accordance with the Companies [Indian Accounting Standards] Rules, 2015 [Ind AS] as amended, prescribed under Section 133 of the Companies Act, 2013, read with relevant rules issued thereunder and in terms of Regulation 33 of Securities and Exchange Board of India [Listing Obligations and Disclosure Requirements] Regulations, 2015, as amended. ). n,e Company operates in one segment, namely "Consumer Products". 4. The Board of directors at their meeting held on May 19, 2025 had approved the split / sub-division of equity shares from face value of { 10/- each to { 2/- each, fully paid-up. The same was effected on September 19, 2025. 5. Exceptional items comprise: Sr. Particulars , in Million No. Quarter Ended Year Ended June March June March 30, 2026 31, 2026 30,202.5 31, 2026 [Unaudited] [Unaudited] [Unaudited] [Audited] Refer Note 7 -i. Expenses related to liquidation of Naturell (India) Private Limited [NIPL] with the Company on a - - - 97 going concern basis [Refer Note-6] ii. One time impact of New Labour Codes - 15 Total - - - 112 6. Pursuant to the voluntary liquidation process, as approved in extra ordinary general meeting of NIPL on July 1, 2025, effective from September 20, 2025, the Liquidator of NIPL has distributed the Business Undertaking of NIPL on a going concern basis with the Company. The entire business operations of NIPL have been consolidated with the Company with effect from September 20, 2025. In view of the requirements of Appendix C to Ind AS 103 ' Business Combination" preceding period figures have been restated from the date of acquisition of NIPL by the Company (i.e. December 02, 2024). 7. The figures of the quart er ended March 31, 2026 are the balancing figures between audited figures in respect of the full financial year and for the period up to the end of the third quarter of relevant financial year. 8. Figures of previous reporting periods have been regrouped/ reclassified wherever necessary to correspond with the figures of the current reporting period. By Order of the Board, For Zydu~• ~~ Dr. harvil P. Patel Place: Ahmedabad Chairman Date: Auaust 4 2026 DIN: 00131995
Page 5
MU KESH M. SHAH & co. CHARTERED ACCOUNT ANTS INDEPENDENT AUDITOR'S REVIEW REPORT ON REVIEW OF INTERIM CONSOLIDATED FINANCIAL RESULTS To, The Board of Directors, Zydus Wellness Limited 1. We have reviewed the accompanying statement of Consolidated unaudited financial results of Zydus Wellness Limited ['the Parent'] and its subsidiaries [the Parent and its subsidiaries together referred to as 'the Group'] for the quarter ended on June 30, 2026 ['the Statement'] attached herewith, being subrnitted by the Parent pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended ("the Listing Regulations"). 2. This statement, which is the responsibility of the Parent's Management and approved by the Parent's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34, 'Interim Financial Reporting', prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the statement based on our review. 3. We conducted our review in accordance with the Standard on Review Engagement (SRE) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Institute of Chartered Accountants of India (ICAI). A review of interim financial information consists of making inquiries, primarily of the Company's personnel responsible for financial and accounting matters and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under Section 143(10) of the Companies Act, 2013 and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion . We also performed procedures in accordance with the circular issued by the SEBI under Listing Regulations, as amended, to the extent applicable. 4. The Statement includes the financial results of the following entities: a) Parent Company i) Zydus Wellness Limited b) Subsidiary Companies i) Zydus Wellness Products Limited ii) Liva Nutritions Limited iii) Alidac UK Limited iv) Comfort Click Softech Private Limited v) Comfort Click Limited, UK vi) Comfort Click Limited, Ireland vii) Comfort Click LLC viii) Zydus Wellness International DMCC ix) Zydus Wellness (BD) Pvt Limited x) Naturell Inc. xi) Zydus Wellness General Trading DWC-LLC xii) Zydus Wellness Trading LLC xiii) Zydus Wellness (EU) Limited +91-79-2647 2000Icontact@mmsco.inIwww.mmsco.in 7th Floor, Heritage Chambers, Behind Bikanerwala Sweets, Near Azad Society, Nehru Nagar, Ahmedabad-380015
Page 6
MU KESH M. SHAH & co. CHARTERED ACCOUNTANTS 5. Based on our review conducted and procedures performed as stated in Paragraph 3 above and based on the consideration of the review reports of the other auditors referred to in paragraph 6 below, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standards and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. 6. We did not review the interim financial information of 6 subsidiary included in the consolidated unaudited financial results, whose interim financial information reflect [the figures reported below are before giving effect to consolidation adjustments] total income of~ 14,855 million for the quarter ended June 30, 2026, total net profit after tax of ~ 1,268 million for the quarter ended June 30, 2026, total comprehensive income of ~ 1,268 million for the quarter ended June 30, 2026, as considered in the Statement. This interim financial information has been reviewed by other auditors whose reports have been furnished to us by the Management and our conclusion on the Statement, in so far as it relates to the amounts and disclosures included in respect of these subsidiaries, is based solely on the reports of the other auditors and the procedures performed by us as stated in paragraph 3 above. Our conclusion on the Statement is not modified in respect of this matter. 7. The consolidated financial results also include the financial information of 5 subsidiary companies included in the consolidated unaudited financial results, whose interim financial information reflects [the figures reported below are before giving effect to consolidation adjustments] total income of ~ 231 million for the quarter ended June 30, 2026, total net Loss after tax of~ 28 million for the quarter ended June 30, 2026, total comprehensive income of ~ (28} million for the quarter ended June 30, 2026, as considered in the Statement. No limited review of this financial information has been carried out by the auditors of the subsidiary; however, according to the information and explanations given to us by the Management, this interim financial results/ information is not material to the Group. Our conclusion on the Statement is not modified in respect of our reliance on the interim financial information as certified by the management . Place: Ahmedabad Date: August 4, 2026 +91-79-2647 2000 I contact@mmsco.in I www.mmsco.in For Mukesh M. Shah & Co Chartered Accountants Firm Regn. No. 106625W Mukesh M. Shah Partner Membership No. 030190 7th Floor, Heritage Chambers, Behind Bikanerwala Sweets, Near Azad Society, Nehru Nagar, Ahmedabad-380015
Page 7
zyd~ Zydus Wellness Limited Registered office : Zydus Corporate Park, Scheme No. 63, Survey No. 536 Khoraj (Gandhinagar), Near Vaishnodevi Circle, wellness Sarkhej-Gandhinagar Highway, Ahmedabad 382 481. /)-~•-· :~ --~•:...,, ~,n; -~ Tel. No. (+ 91-791 '1804 0000 Website: www.zvduswellness.com CIN: L1S201GJ1994PLC023490 Statement of Consolidated Unaudited Financial Results for the Quarter ended June 30, 2026 Sr. Particulars fin Million No. Quarter Ended Year Ended June March June March 30, 2026 31, 2026 30, 2025 31, 2026 [Unaudited] [Unaudited] [Unaudited] [Audited] Refer Note 11 1 Income a Revenue from operations i Sales 14,299 14,761 8,577 39,400 li other operating income 71 86 32 210 Total Revenue from operations 14,370 14,847 8,609 39,610 b other income 38 12 30 64 Total Income 14,408 14,859 8,639 39,674 2 Expenses a Cost of materials consumed 3,076 3,844 2,672 12,123 b Purchases of stock-in-trade 1,426 1,923 512 4,164 C Changes in inventories of finished goods, work-in-progress and stock-in-trade 432 (570) 694 (618) d Employee benefits expense 968 1,046 682 3,130 e Finance costs 263 387 25 981 f Depreciation and amortisation expense 571 553 108 1,467 g Advertisement and promotion expense 2,612 2,411 1,32S 6,459 h other expenses 3,435 3,540 1,171 9,329 i Net [gain]/ loss on foreign currency transactions 4 (48) (3) (74) Total Expenses 12 787 13 086 7 186 36 961 3 Profit before exceptional items and tax [1-21 1,621 1,773 1,453 2,713 4 Exceptional items [Refer Note SJ - - 408 5 Profit before tax [3-4] 1,621 1,773 l,4S3 2,305 5 Tax expense a Current tax 401 117 8 306 b Deferred tax [Refer Note 6] 31 36 166 27 Total tax expense 432 153 174 333 7 Net Profit [5-6] 1189 1 620 1 279 1 972 8 Other Comprehensive Income [OCI] a Items that will not be redassified to profit or loss Re-measurement loss on cost employment defined benefit plan - 1 (2) (S) Income tax effect on above items - 1 Total - 1 (2) (4) b Items that will be reclassined to profit or loss Exchange differences on translation of financial stat~mrnt of foreign operations (11!)) (23) 2 (42) Total (110) (23) 2 - (42) Total Other Comprehensive Income [net of tax] /110) /22) 1461 9 Total Comprehensive Income [7+8] 1,079 1,598 1,279 1,926 10 Paid-up equity share capital [Face Value ~ 2/- each] 636 636 636 636 11 Reserve excluding Revaluation Reserve [i.e. Other equity] 57,624 12 Earnings per share [not annualised for the quarter] [Refer Note 10] a Basic[~] 3.74 5.09 4.02 6.20 b Diluted[~] 3.74 5.09 4.02 6.20 Notes: 1. The above financial results were reviewed by the Audit Committee and then approved by the Board of Directors at their meeting held on August 4, 2026. 2. The above financial results have been prepared in accordance with the Companies [Indian Accounting Standards] Rules, 2015 [Ind AS] as amended, prescribed under Section 133 of the Companies Act, 2013, read with relevant rules issued thereunder and in terms of Regulation 33 of Securities and Excl1ange Board of.India [Listing Obligations and Disclosure Requirements] Regulations, 2015, as amended. 3. The Group operates in one segment, namely "Consumer Products". 4. Due to seasonality of some of the Group's products, Group's Revenues and Group's Profits are skewed in favour of the first and last quarters of the financial year. Hence the performance of these quarters is not representative and cannot be generalised for other quarters. 5. Exceptional items comprise: Sr Particulars fin Million No Ouarter Ended June March June March 30, 2026 31, 2026 30, 2025 31,2026 [Unaudited] [Unaudited] [Unaudited] [Audited] Refer Note 11 i. Expenses related to liquidation of Naturell {India) Private Limited [NIPL], a subsidiary of the 97 Company, on a going concern basis [Refer Note-BJ ii. Expenses related to acquisition of Comfort Click Limited [CCL] [Refer Note-9] 245 iii. One time impact of New Labour Codes 66 Total - - - 408
Page 8
6. Financial results for the quarter ended June 30, 2026, March 31, 2026, and June 30, 2025, and for the year ended March 31, 2026, include a net reversal of Minimum Alternate Tax (MAT) credit entitlement amounting to Nil, Ul8 million, U46 million, and U54 million 1espectively. 7. As on June 30, 2026 the company has following sub,idiaries: i. Zydus Wellness Products Limited ii. Zydus Wellness (BD) Pvt Limited iii. Zydus Wellness International DMCC iv. Liva Nutritions Limited v. Naturell Inc vi. Alidac UK Limited vii. Comfort Click Limited, UK viii. Comfort Click Softech Private Limited ix. Comfort Click Limited, Ireland x. Comfort Click LLC xi. Zydus Wellness General Trading DWC-LLC xii. Zydus Wellness Trading L.L.C. xiii. Zydus Wellness (EU) Limited 8. On July 1, 2025 a special resolution was passed in the extra ordinary general meeting of NIPL to approve the voluntarily liquidation of NIPL on a going concern basis. Pursuant to the same, the Liquidator of NIPL, has distributed the entire business undertaking of NIPL on a going concern basis to the Company on and with effect from September 20, 2025. The entire business operations of NIPL stands consolidated with the Company with effect from September 20, 2025. The Company has given effect of the liquidation as per the requirements of Appendix C to Ind A.S 103 "Business Combination". 9. Pursuant to the Share Purchase Agreement [''SPA" ] entered into by Alidac UK Limited [Alidac], a wholly owned subsidiary of the Company, on August 29, 2025, to acquire Comfort Click Limited [CCL], Alidac has successfully completed the acquisition of CCL on August 29, 2025. Alidac acquired 100% outstanding ordinary shares of Class A and Class B, 71.43% of non-controlling ordinary shares of Class C and 66.67% of non-controlling ordinary shares of Class D of CCL. The cost of acquisition is GBP 239 million, along with a profit-ticker payment of GBP 2.64 million, in accordance with the terms of SPA. The results include the operations of CCL effective from August 29, 2025, with provisional purchase price allocation (PPA] figures. The PPA figures will be finalized within the measurement period, as provided by Ind AS 103 "Business Combination". 10. The Board of directors at their meeting held on May 19, 2025 had approved the split/ sub-division of equity shares from face value of~ 10/- each to~ 2/- each, fully paid-up. The same was effected on September 19, 2025. 11. The figures of the quarter ended March 31, 2026 are the balancing figures between audited figures in respect of the full financial year and for the period up to the end of the third quarter of relevant financial year. 12. Figures of previous reporting periods have been regrouped/ reclassified wherever necessary to correspond with the figures of the current reporting period. 13. The detailed standalone results are available on the Company's website: www.zyduswellness.com, on the website of BSE [www.bseindia.com] and on the website of NSE [www.nseindia.com]. The summarised standalone financial results of the Company are as below: Sr. No Parti culars i. Revenue from operations ii. Profit before exceptional it~ms ;and tax iii. Profit after tax iv. Other Comprehensive Income v. Total Comnrehensive Income Place: Ahmedabad Date: August 4 ,2026 June 30 2026 [Unaudited] 1,530 74 55 - 55 fin Milli on Quarter Ended March June March 31 2026 30 2025 31 2026 [Unaudited] Refer Note 11 1,326 152 133 l 134 [Unaudited] [Audited] 1,409 5,821 79 600 46 376 (2) (3) 44 373 By Order of the Board, For Zydus Wellness Limited, Dr. Sharvil P. Patel Chairman DIN· M1'100<